BioLife Solutions, Inc. (BLFS) vs Anbio Biotechnology (NNNN)

BioLife Solutions, Inc. and Anbio Biotechnology are both Medical Instruments & Supplies companies. BioLife Solutions, Inc. is the larger, with a market value of $1.9B against $884.9M — 2.2× the size. Across the 8 metrics below, BioLife Solutions, Inc. leads on 5 and Anbio Biotechnology on 3.

Valuation

Metric BLFS NNNN Medical Instruments & Supplies median
P/E 32.62 — 34.17
P/S 17.63 — 2.83
P/B 4.48 n/m 2.82
Price to free cash flow 232.01 n/m 25.69
EV/EBITDA 350.25 n/m 16.08
EV/Sales 16.99 n/m 3.06
Earnings yield 3.07% — (1.84%)
Free cash flow yield 0.43% 0.00% 0.17%

Profitability

Metric BLFS NNNN Medical Instruments & Supplies median
Gross margin 63.61% — 54.62%
Operating margin 1.64% — 1.64%
Net margin 54.35% — 0.00%
Free cash flow margin 7.60% 0.00% 1.61%
Return on equity 15.12% 0.00% 0.00%
Return on assets 13.89% 0.00% 0.00%
Return on invested capital 0.32% 0.00% 0.00%

Growth

Metric BLFS NNNN Medical Instruments & Supplies median
Revenue growth (TTM) 30.12% — 9.20%
EPS growth (last fiscal year) 77.27% 150.00% —
Revenue growth, 5-year CAGR 14.88% — 9.48%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BLFS NNNN Medical Instruments & Supplies median
Debt to equity 0.00 0.00 0.08
Current ratio 9.69 344.45 2.49
Net debt to EBITDA 7.04 (2.06) 0.83

Dividend

Metric BLFS NNNN Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio 0.00 — 0.00

Size

Metric BLFS NNNN Medical Instruments & Supplies median
Market cap 1.91b 884.93m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack